Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Prelamellar Dissection Donor Corneal Thickness Is Associated With Descemet Stripping Automated Endothelial Keratoplasty Operative Complications in the Cornea Preservation Time Study.

Ross KW, Stoeger CG, Rosenwasser GOD, OʼBrien RC, Szczotka-Flynn LB, Ayala AR, Maguire MG, Benetz BA, Dahl P, Drury DC, Dunn SP, Farazdaghi SM, Hoover CK, Macsai MS, Mian SI, Nordlund ML, Penta JG, Soper MC, Terry MA, Verdier DD, Williams DV, Lass JH; Cornea Preservation Time Study Group.

Cornea. 2019 Jun 5. doi: 10.1097/ICO.0000000000002040. [Epub ahead of print]

PMID:
31180926
2.

Impact of Dry Eye on Visual Acuity and Contrast Sensitivity: Dry Eye Assessment and Management Study.

Szczotka-Flynn LB, Maguire MG, Ying GS, Lin MC, Bunya VY, Dana R, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Research Group.

Optom Vis Sci. 2019 Jun;96(6):387-396. doi: 10.1097/OPX.0000000000001387.

PMID:
31116166
3.

Linking OCT, Angiographic, and Photographic Lesion Components in Neovascular Age-Related Macular Degeneration.

Toth CA, Tai V, Chiu SJ, Winter K, Sevilla MB, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Pistilli M, Farsiu S, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmol Retina. 2018 May;2(5):481-493. doi: 10.1016/j.oret.2017.09.016. Epub 2017 Nov 28.

PMID:
31047330
4.

Grading and baseline characteristics of meibomian glands in meibography images and their clinical associations in the Dry Eye Assessment and Management (DREAM) study.

Daniel E, Maguire MG, Pistilli M, Bunya VY, Massaro-Giordano GM, Smith E, Kadakia PA, Asbell PA; Dry Eye Assessment and Management (DREAM) Study Research Group.

Ocul Surf. 2019 Apr 22. pii: S1542-0124(19)30040-0. doi: 10.1016/j.jtos.2019.04.003. [Epub ahead of print]

PMID:
31022469
5.

Updated Methods for Assessing the Risk of Progression to Late Age-Related Macular Degeneration.

Maguire MG.

JAMA Ophthalmol. 2019 Apr 25. doi: 10.1001/jamaophthalmol.2019.0918. [Epub ahead of print] No abstract available.

PMID:
31021385
6.

A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned.

Ervin AM, Strauss RW, Ahmed MI, Birch D, Cheetham J, Ferris FL 3rd, Ip MS, Jaffe GJ, Maguire MG, Schönbach EM, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

Transl Vis Sci Technol. 2019 Apr 12;8(2):16. doi: 10.1167/tvst.8.2.16. eCollection 2019 Apr.

7.

Distribution of OCT Features within Areas of Macular Atrophy or Scar after 2 Years of Anti-VEGF Treatment for Neovascular AMD in CATT.

Toth CA, Tai V, Pistilli M, Chiu SJ, Winter KP, Daniel E, Grunwald JE, Jaffe GJ, Martin DF, Ying GS, Farsiu S, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmol Retina. 2019 Apr;3(4):316-325. doi: 10.1016/j.oret.2018.11.011. Epub 2018 Dec 3.

PMID:
31014683
8.

Effect of Graft Attachment Status and Intraocular Pressure on DSAEK Outcomes in the Cornea Preservation Time Study.

Aldave AJ, Terry MA, Szczotka-Flynn LB, Liang W, Ayala AR, Maguire MG, O'Brien RC, Benetz BA, Bokosky JE, Dunn SP, Gillette TE, Hammersmith KM, Hardten DR, Jeng BH, Jones MF, Lindstrom RL, Maverick KJ, Nirankari VS, Oliva MS, Raber IM, Rapuano CJ, Rosenwasser GOD, Ross KW, Seedor JW, Shamie N, Stoeger CG, Tauber S, Van Meter WS, Verdier DD, Lass JH; Cornea Preservation Time Study Group.

Am J Ophthalmol. 2019 Mar 6. pii: S0002-9394(19)30088-1. doi: 10.1016/j.ajo.2019.02.029. [Epub ahead of print]

PMID:
30849341
9.

Postoperative Endothelial Cell Density Is Associated with Late Endothelial Graft Failure after Descemet Stripping Automated Endothelial Keratoplasty.

Patel SV, Lass JH, Benetz BA, Szczotka-Flynn LB, Cohen NJ, Ayala AR, Maguire MG, Drury DC, Dunn SP, Jeng BH, Jones MF, Menegay HJ, Oliva MS, Rosenwasser GOD, Seedor JA, Terry MA, Verdier DD; Cornea Preservation Time Study Group.

Ophthalmology. 2019 Feb 18. pii: S0161-6420(18)32753-2. doi: 10.1016/j.ophtha.2019.02.011. [Epub ahead of print]

PMID:
30790587
10.

Factors Associated With Visual Acuity and Central Subfield Thickness Changes When Treating Diabetic Macular Edema With Anti-Vascular Endothelial Growth Factor Therapy: An Exploratory Analysis of the Protocol T Randomized Clinical Trial.

Bressler SB, Odia I, Maguire MG, Dhoot DS, Glassman AR, Jampol LM, Marcus DM, Solomon SD, Sun JK; Diabetic Retinopathy Clinical Research Network.

JAMA Ophthalmol. 2019 Jan 24. doi: 10.1001/jamaophthalmol.2018.6786. [Epub ahead of print]

PMID:
30676635
11.

Comparison of Donor Cornea Endothelial Cell Density Determined by Eye Banks and by a Central Reading Center in the Cornea Preservation Time Study.

Benetz BA, Stoeger CG, Patel SV, OʼBrien RC, Szczotka-Flynn LB, Ayala AR, Maguire MG, Menegay HJ, Bedard P, Clover JM, Gupta PC, McCoy KE, Song JC, Lass JH; Cornea Preservation Time Study Group.

Cornea. 2019 Apr;38(4):426-432. doi: 10.1097/ICO.0000000000001846.

PMID:
30664048
12.

Five-Year Follow-up of Nonfibrotic Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Daniel E, Ying GS, Kim BJ, Toth CA, Ferris F 3rd, Martin DF, Grunwald JE, Jaffe GJ, Dunaief JL, Pan W, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials.

Ophthalmology. 2019 May;126(5):743-751. doi: 10.1016/j.ophtha.2018.11.020. Epub 2018 Nov 23.

PMID:
30476517
13.

Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study.

Lass JH, Benetz BA, Patel SV, Szczotka-Flynn LB, O'Brien R, Ayala AR, Maguire MG, Daoud YJ, Greiner MA, Hannush SB, Lee WB, Mauger TF, Menegay HJ, Mifflin MD, Raizman MB, Rose-Nussbaumer J, Schultze RL, Schmidt GA, Sugar A, Terry MA, Verdier DD; Cornea Preservation Time Study Group.

JAMA Ophthalmol. 2018 Oct 26. doi: 10.1001/jamaophthalmol.2018.5669. [Epub ahead of print]

PMID:
30422157
14.

Factors Associated With Graft Rejection in the Cornea Preservation Time Study.

Stulting RD, Lass JH, Terry MA, Benetz BA, Cohen NJ, Ayala AR, Maguire MG, Croasdale C, Daoud YJ, Dunn SP, Goins KM, Gupta PC, Macsai MS, Mian SI, Pramanik S, Rose-Nussbaumer J, Song JC, Stark WJ, Sugar A, Verdier DD, Szczotka-Flynn LB; Cornea Preservation Time Study Group.

Am J Ophthalmol. 2018 Dec;196:197-207. doi: 10.1016/j.ajo.2018.10.005. Epub 2018 Oct 9.

PMID:
30308200
15.

CHANGES IN DIABETIC RETINOPATHY SEVERITY WHEN TREATING DIABETIC MACULAR EDEMA WITH RANIBIZUMAB: DRCR.net Protocol I 5-Year Report.

Bressler SB, Odia I, Glassman AR, Danis RP, Grover S, Hampton GR, Jampol LM, Maguire MG, Melia M.

Retina. 2018 Oct;38(10):1896-1904. doi: 10.1097/IAE.0000000000002302.

PMID:
30234859
16.

Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.

Jaffe GJ, Ying GS, Toth CA, Daniel E, Grunwald JE, Martin DF, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2019 Feb;126(2):252-260. doi: 10.1016/j.ophtha.2018.08.035. Epub 2018 Sep 3.

PMID:
30189282
17.

Prevalence of Novel Candidate Sjogren Syndrome Autoantibodies in the Dry Eye Assessment and Management (DREAM) Study.

Bunya VY, Ying GS, Maguire MG, Kuklinski E, Lin MC, Peskin E, Asbell PA; DREAM Study Research Group.

Cornea. 2018 Nov;37(11):1425-1430. doi: 10.1097/ICO.0000000000001714.

PMID:
30161055
18.

ASSOCIATION BETWEEN ORAL IRON SUPPLEMENTATION AND RETINAL OR SUBRETINAL HEMORRHAGE IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS.

Song D, Ying GS, Dunaief JL, Bhuyan R, Li Y, Maguire MG, Grunwald JE, Daniel E, Hagstrom S, Martin DF; Comparison of Age-Related Macular Degeneration Treatment Trial Research Group.

Retina. 2018 Aug 28. doi: 10.1097/IAE.0000000000002295. [Epub ahead of print]

PMID:
30157115
19.

n-3 Fatty Acid Supplementation and Dry Eye Disease.

Maguire MG, Asbell PA; DREAM Study Research Group.

N Engl J Med. 2018 Aug 16;379(7):691. doi: 10.1056/NEJMc1807693. No abstract available.

PMID:
30124262
20.

Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study.

Terry MA, Aldave AJ, Szczotka-Flynn LB, Liang W, Ayala AR, Maguire MG, Croasdale C, Daoud YJ, Dunn SP, Hoover CK, Macsai MS, Mauger TF, Pramanik S, Rosenwasser GOD, Rose-Nussbaumer J, Stulting RD, Sugar A, Tu EY, Verdier DD, Yoo SH, Lass JH; Cornea Preservation Time Study Group.

Ophthalmology. 2018 Nov;125(11):1700-1709. doi: 10.1016/j.ophtha.2018.08.002. Epub 2018 Aug 9.

PMID:
30098353
21.

Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T.

Bressler NM, Beaulieu WT, Maguire MG, Glassman AR, Blinder KJ, Bressler SB, Gonzalez VH, Jampol LM, Melia M, Sun JK, Wells JA 3rd; Diabetic Retinopathy Clinical Research Network.

Am J Ophthalmol. 2018 Nov;195:93-100. doi: 10.1016/j.ajo.2018.07.030. Epub 2018 Aug 2.

PMID:
30077569
22.

Baseline Predictors for Five-Year Visual Acuity Outcomes in the Comparison of AMD Treatment Trials.

Ying GS, Maguire MG, Pan W, Grunwald JE, Daniel E, Jaffe GJ, Toth CA, Hagstrom SA, Martin DF; CATT Research Group.

Ophthalmol Retina. 2018 Jun;2(6):525-530. doi: 10.1016/j.oret.2017.10.003.

23.

Incidence and Outcomes of Positive Donor Rim Cultures and Infections in the Cornea Preservation Time Study.

Mian SI, Aldave AJ, Tu EY, Ayres BD, Jeng BH, Macsai MS, Nordlund ML, Penta JG, Pramanik S, Szczotka-Flynn LB, Ayala AR, Liang W, Maguire MG, Lass JH.

Cornea. 2018 Sep;37(9):1102-1109. doi: 10.1097/ICO.0000000000001654.

PMID:
29912040
24.

Dry Eye Assessment and Management (DREAM©) Study: Study design and baseline characteristics.

Asbell PA, Maguire MG, Peskin E, Bunya VY, Kuklinski EJ; Dry Eye Assessment and Management (DREAM©) Study Research Group.

Contemp Clin Trials. 2018 Aug;71:70-79. doi: 10.1016/j.cct.2018.06.002. Epub 2018 Jun 6.

PMID:
29883769
25.

A new scale for the assessment of conjunctival bulbar redness.

Macchi I, Bunya VY, Massaro-Giordano M, Stone RA, Maguire MG, Zheng Y, Chen M, Gee J, Smith E, Daniel E.

Ocul Surf. 2018 Oct;16(4):436-440. doi: 10.1016/j.jtos.2018.06.003. Epub 2018 Jun 6.

PMID:
29883738
26.

Understanding Variation in Response to Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration.

Maguire MG.

JAMA Ophthalmol. 2018 Aug 1;136(8):884-885. doi: 10.1001/jamaophthalmol.2018.0032. No abstract available.

PMID:
29852031
27.

Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials.

Lin LY, Zhou Q, Hagstrom S, Maguire MG, Daniel E, Grunwald JE, Martin DF, Ying GS; CATT Research Group.

JAMA Ophthalmol. 2018 Jun 1;136(6):682-688. doi: 10.1001/jamaophthalmol.2018.1231.

28.

Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.

O'Neil EC, Huang J, Suhler EB, Dunn JP Jr, Perez VL, Gritz DC, McWilliams K, Peskin E, Ying GS, Bunya VY, Maguire MG, Kempen JH.

Br J Ophthalmol. 2018 Aug;102(8):1011-1013. doi: 10.1136/bjophthalmol-2017-311610. Epub 2018 Apr 17.

PMID:
29666122
29.

n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.

Dry Eye Assessment and Management Study Research Group, Asbell PA, Maguire MG, Pistilli M, Ying GS, Szczotka-Flynn LB, Hardten DR, Lin MC, Shtein RM.

N Engl J Med. 2018 May 3;378(18):1681-1690. doi: 10.1056/NEJMoa1709691. Epub 2018 Apr 13.

30.

Development and Course of Scars in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, Jaffe GJ, Toth CA, Martin DF, Fine SL, Maguire MG; Comparison of Age-related Macular Degeneration Treatments Trials.

Ophthalmology. 2018 Jul;125(7):1037-1046. doi: 10.1016/j.ophtha.2018.01.004. Epub 2018 Feb 14.

PMID:
29454660
31.

SYSTEMIC BETA-BLOCKERS AND RISK OF PROGRESSION TO NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Kolomeyer AM, Maguire MG, Pan W, VanderBeek BL.

Retina. 2019 May;39(5):918-925. doi: 10.1097/IAE.0000000000002059.

PMID:
29394237
32.

Development and Evaluation of Semiautomated Quantification of Lissamine Green Staining of the Bulbar Conjunctiva From Digital Images.

Bunya VY, Chen M, Zheng Y, Massaro-Giordano M, Gee J, Daniel E, O'Sullivan R, Smith E, Stone RA, Maguire MG.

JAMA Ophthalmol. 2017 Oct 1;135(10):1078-1085. doi: 10.1001/jamaophthalmol.2017.3346.

33.

Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Daniel E, Grunwald JE, Kim BJ, Maguire MG, Jaffe GJ, Toth CA, Ferris FL 3rd, Martin DF, Shaffer J, Ying GS; Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmol Retina. 2017 Jan-Feb;1(1):25-33. doi: 10.1016/j.oret.2016.09.001.

34.

Tutorial on Biostatistics: Statistical Analysis for Correlated Binary Eye Data.

Ying GS, Maguire MG, Glynn R, Rosner B.

Ophthalmic Epidemiol. 2018 Feb;25(1):1-12. doi: 10.1080/09286586.2017.1320413. Epub 2017 May 22.

35.

Comparison of cycloplegic refraction between Grand Seiko autorefractor and Retinomax autorefractor in the Vision in Preschoolers-Hyperopia in Preschoolers (VIP-HIP) Study.

Ying GS, Maguire MG, Kulp MT, Ciner E, Moore B, Pistilli M, Candy R; VIP-HIP Study Group.

J AAPOS. 2017 Jun;21(3):219-223.e3. doi: 10.1016/j.jaapos.2017.05.008. Epub 2017 May 18.

36.

Association between pseudodrusen and delayed patchy choroidal filling in the comparison of age-related macular degeneration treatments trials.

Zhou Q, Daniel E, Grunwald JE, Maguire MG, Gewaily DY, Martin DF, Ying GS; CATT Research Group.

Acta Ophthalmol. 2017 Sep;95(6):e518-e520. doi: 10.1111/aos.13398. Epub 2017 Mar 8. No abstract available.

37.

Use of Crossed Polarizers to Enhance Images of the Eyelids.

OʼSullivan R, Tom LM, Bunya VY, Nyberg WC, Massaro-Giordano M, Daniel E, Smith E, Brainard DH, Gee J, Maguire MG, Stone RA.

Cornea. 2017 May;36(5):631-635. doi: 10.1097/ICO.0000000000001157.

38.

Reply.

Maguire MG; CATT Research Group.

Ophthalmology. 2017 Mar;124(3):e33. doi: 10.1016/j.ophtha.2016.06.046. No abstract available.

PMID:
28219518
39.

Tutorial on Biostatistics: Linear Regression Analysis of Continuous Correlated Eye Data.

Ying GS, Maguire MG, Glynn R, Rosner B.

Ophthalmic Epidemiol. 2017 Apr;24(2):130-140. doi: 10.1080/09286586.2016.1259636. Epub 2017 Jan 19.

40.

Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.

Grunwald JE, Pistilli M, Daniel E, Ying GS, Pan W, Jaffe GJ, Toth CA, Hagstrom SA, Maguire MG, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2017 Jan;124(1):97-104. doi: 10.1016/j.ophtha.2016.09.012. Epub 2016 Oct 27.

41.

Further Scrutiny of Vision Outcomes When Aflibercept Is Used as Rescue Treatment for Eyes With Diabetic Macular Edema Treated With Laser.

Maguire MG.

JAMA Ophthalmol. 2017 Feb 1;135(2):114-115. doi: 10.1001/jamaophthalmol.2016.4936. No abstract available.

PMID:
28006049
42.

Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular Edema.

Ferris FL 3rd, Maguire MG, Glassman AR, Ying GS, Martin DF.

JAMA Ophthalmol. 2017 Feb 1;135(2):145-149. doi: 10.1001/jamaophthalmol.2016.4820.

PMID:
28006042
43.

Visual Function of Moderately Hyperopic 4- and 5-Year-Old Children in the Vision in Preschoolers - Hyperopia in Preschoolers Study.

Ciner EB, Kulp MT, Maguire MG, Pistilli M, Candy TR, Moore B, Ying GS, Quinn G, Orlansky G, Cyert L; Vision In Preschoolers - Hyperopia In Preschoolers (VIP-HIP) Study Group Writing Committee.

Am J Ophthalmol. 2016 Oct;170:143-152. doi: 10.1016/j.ajo.2016.07.017. Epub 2016 Jul 29.

44.

Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL.

Ophthalmology. 2016 Aug;123(8):1751-1761. doi: 10.1016/j.ophtha.2016.03.045. Epub 2016 May 2.

45.

Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Maguire MG, Ying GS, Jaffe GJ, Toth CA, Daniel E, Grunwald J, Martin DF, Hagstrom SA; CATT Research Group.

JAMA Ophthalmol. 2016 Jun 1;134(6):674-81. doi: 10.1001/jamaophthalmol.2016.0669.

46.

Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Zhou Q, Daniel E, Maguire MG, Grunwald JE, Martin ER, Martin DF, Ying GS; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Jul;123(7):1530-40. doi: 10.1016/j.ophtha.2016.02.043. Epub 2016 Apr 1.

47.

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.

Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Apr;123(4):865-75. doi: 10.1016/j.ophtha.2015.12.002. Epub 2016 Jan 9.

48.

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Shah N, Maguire MG, Martin DF, Shaffer J, Ying GS, Grunwald JE, Toth CA, Jaffe GJ, Daniel E; Comparison of Age-related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Apr;123(4):858-64. doi: 10.1016/j.ophtha.2015.11.030. Epub 2016 Jan 8.

49.

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).

Daniel E, Shaffer J, Ying GS, Grunwald JE, Martin DF, Jaffe GJ, Maguire MG; Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group.

Ophthalmology. 2016 Mar;123(3):609-16. doi: 10.1016/j.ophtha.2015.10.034. Epub 2015 Dec 8.

50.

Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Ying GS, Maguire MG, Daniel E, Grunwald JE, Ahmed O, Martin DF; Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.

Ophthalmology. 2016 Feb;123(2):352-60. doi: 10.1016/j.ophtha.2015.09.046. Epub 2015 Nov 4.

Supplemental Content

Loading ...
Support Center